Authors: Behbahani, H Landay, A Patterson, BK Jones, P Pottage, J Agnoli, M Andersson, J Spetz, AL

Citation: H. Behbahani et al., Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy, J ACQ IMM D, 25(2), 2000, pp. 150-156

Authors: Fichtenbaum, CJ Koletar, S Yiannoutsos, C Holland, F Pottage, J Cohn, SE Walawander, A Frame, P Feinberg, J Saag, M Van der Horst, C Powderly, WG

Citation: Cj. Fichtenbaum et al., Refractory mucosal candidiasis in advanced human immunodeficiency virus infection, CLIN INF D, 30(5), 2000, pp. 749-756

Authors: Al-Harthi, L Siegel, J Spritzler, J Pottage, J Agnoli, M Landay, A

Citation: L. Al-harthi et al., Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease, AIDS, 14(7), 2000, pp. 761-770

Authors: Eron, JJ Murphy, RL Peterson, D Pottage, J Parenti, DM Jemsek, J Swindells, S Sepulveda, G Bellos, N Rashbaum, BC Esinhart, J Schoellkopf, N Grosso, R Stevens, M

Citation: Jj. Eron et al., A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II), AIDS, 14(11), 2000, pp. 1601-1610

Authors: Pollard, RB Peterson, D Hardy, D Pottage, J Murphy, RL Gathe, J Beall, G Rutkievicz, V Reynolds, L Cross, AP Dunkle, LM

Citation: Rb. Pollard et al., Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm(3), J ACQ IMM D, 22(1), 1999, pp. 39-48

Authors: Patterson, BK Czerniewski, MA Pottage, J Agnoli, M Kessler, H Landay, A

Citation: Bk. Patterson et al., Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation, LANCET, 353(9148), 1999, pp. 211-212